AR078118A1 - Formulacion antifungica que comprende luliconazol. kit. articulo de fabricacion. - Google Patents

Formulacion antifungica que comprende luliconazol. kit. articulo de fabricacion.

Info

Publication number
AR078118A1
AR078118A1 ARP100100426A ARP100100426A AR078118A1 AR 078118 A1 AR078118 A1 AR 078118A1 AR P100100426 A ARP100100426 A AR P100100426A AR P100100426 A ARP100100426 A AR P100100426A AR 078118 A1 AR078118 A1 AR 078118A1
Authority
AR
Argentina
Prior art keywords
luliconazole
percent
weight
compositions
composition according
Prior art date
Application number
ARP100100426A
Other languages
English (en)
Inventor
Charles Gregory Vontz
Norifumi Nakamura
Porceri-Morton Catherine De
Jeff Hughes
Bhavesh Shah
Peter Gertas
Vitthal Kulkarni
Original Assignee
Topica Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topica Pharmaceuticals Inc filed Critical Topica Pharmaceuticals Inc
Publication of AR078118A1 publication Critical patent/AR078118A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones y formulaciones que comprenden un agente antifungico. Composiciones farmacéuticas que comprenden luliconazol en una cantidad efectiva para el tratamientote onicomicosis. Métodos para el tratamiento de dermatomicosis y onicomicosis usando las composiciones y las formulaciones. Reivindicacion 1: Una composicion farmacéutica que comprende aproximadamente 5 por ciento en peso hasta aproximadamente 15 por ciento en peso de luliconazol, un alcohol, una cetona y un solvente aprotico polar. Reivindicacion 9: La composicion de acuerdo con cualquiera de las reivindicaciones precedentes en donde el derivado de etilenglicol es éter monoetílico de dietilenglicol. Reivindicacion 23: La composicion de acuerdo con cualquiera de las reivindicaciones precedentes, en donde la composicion también comprende un agente formador de película en desde 0,01 por ciento en peso hasta aproximadamente 4 por ciento en peso. Reivindicacion 24: La composicion de acuerdo con la reivindicacion 23, en donde el agente formador de película es un copolímero de anhídrido maleico/éter metilvinílico. Reivindicacion 68: Un método para preparar una composicion farmacéutica que comprende luliconazol, en donde el método comprende la combinacion de luliconazol con un derivado de etilenglicol, un alcohol, una cetona, un solvente aprotico polar.
ARP100100426A 2009-02-13 2010-02-15 Formulacion antifungica que comprende luliconazol. kit. articulo de fabricacion. AR078118A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15265809P 2009-02-13 2009-02-13
US16266109P 2009-03-23 2009-03-23

Publications (1)

Publication Number Publication Date
AR078118A1 true AR078118A1 (es) 2011-10-19

Family

ID=42560491

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100100426A AR078118A1 (es) 2009-02-13 2010-02-15 Formulacion antifungica que comprende luliconazol. kit. articulo de fabricacion.

Country Status (9)

Country Link
US (4) US8193232B2 (es)
EP (2) EP2745692A1 (es)
JP (1) JP5654497B2 (es)
CN (1) CN102395274B (es)
AR (1) AR078118A1 (es)
CA (1) CA2752557A1 (es)
ES (1) ES2468540T3 (es)
IL (1) IL214615A0 (es)
WO (1) WO2010093992A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8349882B2 (en) 2006-03-08 2013-01-08 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
RU2419429C2 (ru) 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
JP5453093B2 (ja) 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP5345937B2 (ja) * 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
CN101808637B (zh) * 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
EP2745692A1 (en) 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102481286B (zh) * 2009-08-25 2014-02-26 宝丽制药股份有限公司 抗真菌药物组合物
EP2579847A1 (en) 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
RU2555509C2 (ru) 2010-12-20 2015-07-10 Колгейт-Палмолив Компани Инкапсулированная в желатине композиция для ухода за полостью рта, содержащая гидрофильный активный ингредиент, гидрофобный структурирующий ингредиент и масляный носитель
US20130078705A1 (en) * 2011-09-22 2013-03-28 Hsuehkuan Lu Protease for treating nail abnormalities
JP5980700B2 (ja) * 2012-03-19 2016-08-31 株式会社ポーラファルマ 抗真菌医薬組成物が充填された樹脂容器
CN104619320A (zh) * 2012-09-14 2015-05-13 宝丽制药股份有限公司 含有卢立康唑的药物组合物
JP5460797B1 (ja) * 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
CN104619703A (zh) * 2012-09-14 2015-05-13 宝丽制药股份有限公司 具有结晶习性的晶体以及通过对所述晶体进行加工获得的药物组合物
CN104619704B (zh) 2012-09-14 2017-12-05 宝丽制药股份有限公司 表面自由能用于分化评价晶体的用途，基于表面自由能作为指标评价的晶体，以及通过包含所述晶体制备的药物组合物
IN2015DN02929A (es) 2012-09-14 2015-09-18 Pola Pharma Inc
JP5722364B2 (ja) * 2013-02-08 2015-05-20 株式会社ポーラファルマ 医薬組成物
JP5662495B2 (ja) * 2013-02-08 2015-01-28 株式会社ポーラファルマ 可溶化剤形の医薬組成物
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
EP3854389A1 (en) * 2013-03-15 2021-07-28 Vapogenix, Inc. Novel analgesic compositions
JP6503627B2 (ja) * 2013-03-28 2019-04-24 大正製薬株式会社 医薬液体組成物
JP2016518306A (ja) * 2013-05-17 2016-06-23 株式会社ポーラファルマ アスペルギルス、カンジダ等を病原体とする疾患用の医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
MX363386B (es) 2013-10-03 2019-03-20 Dow Pharmaceutical Sciences Formulaciones de efinaconazol estabilizadas.
KR102612453B1 (ko) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 항­감염 방법，조성물，및 장치
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
US9480746B2 (en) 2014-04-21 2016-11-01 Pola Pharma Inc. Resin container filled with antifungal pharmaceutical composition
US10493115B2 (en) * 2016-10-21 2019-12-03 Karen Drake Extract for treating skin conditions
WO2019003098A1 (en) * 2017-06-29 2019-01-03 Zenvision Pharma Llp TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING MICONAZOLE AND LULICONAZOLE OR SALTS THEREOF
FR3076555B1 (fr) * 2018-01-11 2020-01-24 Jafer Enterprises R&D Sl Materiau polymerique solide impregne d'une substance organique volatile et d'un ester particulier et ses utilisations
TW201938141A (zh) * 2018-02-21 2019-10-01 瑞士商諾華公司 基於脂質的眼用乳劑
US11730699B2 (en) 2018-02-21 2023-08-22 Alcon Inc. Lipid-based ophthalmic emulsion
CN110146641B (zh) * 2019-05-24 2020-07-07 贵州医科大学 一种蓖麻叶的鉴定方法
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
CN112022838B (zh) * 2020-09-17 2022-08-19 澳美制药厂有限公司 抗真菌药物组合物及其制备方法和成膜凝胶
WO2022059027A1 (en) * 2020-09-18 2022-03-24 Alkem Laboratories Limited Luliconazole Topical Composition
US20230374167A1 (en) * 2022-05-18 2023-11-23 Canon Kabushiki Kaisha Photocurable composition
CN116183736B (zh) * 2022-07-25 2024-02-09 北京和合医学诊断技术股份有限公司 同时检测肺泡灌洗液中9种抗生素的lc-ms/ms分析方法

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76519B (es) * 1981-04-29 1984-08-10 Pfizer
DE3587252T2 (de) * 1985-10-09 1993-07-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
US4738976A (en) * 1985-10-10 1988-04-19 Nihon Nohyaku Co., Ltd. Antimycotic agent and fungicidal agent
HU200914B (en) 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
JP3030780B2 (ja) 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤
JP3573803B2 (ja) 1994-02-16 2004-10-06 ポーラ化成工業株式会社 皮膚外用剤
JP3081766B2 (ja) * 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
AU3673195A (en) 1994-10-13 1996-05-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for nail ringworm
JP2951725B2 (ja) * 1994-10-13 1999-09-20 久光製薬株式会社 爪白癬用外用組成物
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
ES2137888B1 (es) * 1995-07-08 2001-01-01 Nihon Nohyaku Co Ltd Agente antifungico, compuesto para el mismo procedimiento para su produccion y metodo para su utilizacion.
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US5993790A (en) * 1997-08-04 1999-11-30 Pedinol Pharmacal Inc. Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections
BR9904780A (pt) * 1998-02-09 2000-03-08 Macrochem Corp Esmalte fungicida para unhas e método de uso do mesmo
DE19806348A1 (de) * 1998-02-12 1999-08-19 Schering Ag 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln
US6159977A (en) * 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
JP2001064206A (ja) 1999-08-30 2001-03-13 Isp Japan Kk 経皮吸収促進組成物
KR20030016227A (ko) * 2000-02-16 2003-02-26 벤트레이 파마슈티칼스, 인코포레이티드 약학적 조성물
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6750291B2 (en) * 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
US8039452B2 (en) * 2002-06-18 2011-10-18 Pola Pharma Inc. Antifungal medicinal compositions
MXPA05002065A (es) * 2002-09-05 2005-06-08 Galderma Sa Solucion para aplicacion ungueal.
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US7241456B2 (en) * 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
HUE045608T2 (hu) * 2003-06-06 2020-01-28 Univ Texas Antimikrobiális öblítõoldatok
JP3783104B2 (ja) 2004-03-31 2006-06-07 小林製薬株式会社 抗真菌性外用組成物
WO2006097793A2 (en) * 2004-04-15 2006-09-21 Chiasma, Ltd. Compositions capable of facilitating penetration across a biological barrier
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US20070196325A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for dermally treating infections
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
JP3800232B2 (ja) 2004-09-30 2006-07-26 小林製薬株式会社 抗真菌性外用組成物
US7360929B2 (en) * 2005-04-15 2008-04-22 Sylvan R. Shemitz Designs, Inc. Luminaire with multi-purpose mounting feature
US7957805B2 (en) * 2005-06-01 2011-06-07 Boston Scientific Neuromodulation Corporation Implantable microstimulator with external electrodes disposed on a film substrate and methods of manufacture and use
CA2612456C (en) * 2005-06-16 2017-06-06 Warner Chilcott Company, Inc. Gel compositions for topical administration
WO2007022090A2 (en) * 2005-08-13 2007-02-22 Collegium Pharmaceutical, Inc. Topical delivery with a carrier fluid
PL1931309T3 (pl) * 2005-09-29 2013-02-28 Novartis Ag Kompozycja przeciwgrzybicza
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
AU2006326388B2 (en) 2005-12-14 2013-01-24 Nuvo Research Inc. Compositions and methods for treating dermatological conditions
EP1959928A2 (en) 2005-12-14 2008-08-27 Zars, Inc. Spray-on formulations and methods for dermal delivery of drugs
EP1970076A4 (en) * 2005-12-28 2012-12-12 Teikoku Seiyaku Kk PHARMACEUTICAL COMPOSITION FOR APPLYING TO A NAIL
WO2007098591A2 (en) 2006-03-02 2007-09-07 Nuvo Research Inc. Topical nail formulation
CA2645073A1 (en) * 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin
WO2007102243A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
US8349882B2 (en) * 2006-03-08 2013-01-08 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
RU2419429C2 (ru) * 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
AU2007260739A1 (en) * 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
WO2008098158A1 (en) * 2007-02-08 2008-08-14 Dermworx, Incorporated Local anti-infective agent for treatment of nail fungal infections
US8492421B2 (en) 2007-08-27 2013-07-23 Nihon Nohyaku Co., Ltd. Agent for fungal dermatitis
JP5345937B2 (ja) * 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
JP5453093B2 (ja) * 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
CN101808637B (zh) * 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
GB0720716D0 (en) 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
CN102014872A (zh) * 2007-12-21 2011-04-13 先灵-普劳健康护理产品公司 减少或防止皮肤失水的组合物和方法
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US20090258070A1 (en) * 2008-04-15 2009-10-15 John Burnier Topical LFA-1 antagonists for use in localized treatment of immune related disorders
EP2745692A1 (en) 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2416758B8 (en) * 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
FR2954163B1 (fr) 2009-12-18 2012-03-16 Galderma Pharma Sa Utilisation d'un tensioactif cationique, avantageu-sement amphotere, pour la preparation d'une composition antifongique applicable sur l'ongle

Also Published As

Publication number Publication date
US20100210703A1 (en) 2010-08-19
WO2010093992A1 (en) 2010-08-19
EP2395839A4 (en) 2012-06-27
CN102395274A (zh) 2012-03-28
US20130123318A1 (en) 2013-05-16
ES2468540T3 (es) 2014-06-16
IL214615A0 (en) 2011-09-27
JP2012518009A (ja) 2012-08-09
US8193233B2 (en) 2012-06-05
CA2752557A1 (en) 2010-08-19
US20120071533A1 (en) 2012-03-22
JP5654497B2 (ja) 2015-01-14
US20100210702A1 (en) 2010-08-19
EP2395839A1 (en) 2011-12-21
US8193232B2 (en) 2012-06-05
US8362059B2 (en) 2013-01-29
EP2395839B1 (en) 2014-05-07
EP2745692A1 (en) 2014-06-25
CN102395274B (zh) 2014-03-12

Similar Documents

Publication Publication Date Title
AR078118A1 (es) Formulacion antifungica que comprende luliconazol. kit. articulo de fabricacion.
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
ECSP14004812A (es) Triazolopiridinas sustituidas
PE20191043A1 (es) Composicion farmaceutica
CU20120084A7 (es) Compuestos derivados de triazolopiridina sustituidos como inhibidores de la quinasa mps-1 y compuestos intermediarios para su preparación
BR112014032910A2 (pt) solfactants de éter de glicerina etoxilado
ECSP13013011A (es) Triazolopiridinas
GT201400043A (es) Imidazopiridazinas sustituidas con amino
UY33598A (es) Imidazopiridazinas sustituidas
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
CL2008003274A1 (es) Metod para el tratamiento de cultivos que comprende preparar una solucion de pulverizacion mezclando una composicion agroquimica, glicerol crudo derivado de la produccion de biodiesel y aplicar dicha solucion al acultivo y/o malezas y/o su habitat; la solucion de pulverizacion y uso de dicho glicerol para prepararla.
AR107967A1 (es) Ácido hialurónico modificado, método para su preparación y usos del mismo
AR082566A1 (es) Formulaciones liquidas de st-246 y metodos relacionados, proceso
AR083864A1 (es) Producto para el cuidado oral y metodo para su uso y fabricacion
MX2018000894A (es) Composicion de fragancia a base de agua, dispositivo de suministro de fragancia, y metodo para proporcionar un perfume de larga duracion.
BR112014016661A2 (pt) formulação de liberação prolongada para reduzir a frequência de urinação e método de uso da mesma
UY36460A (es) Pirazolpiridinaminas
NZ603828A (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
AR116996A1 (es) Mezclas y composiciones que comprenden 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2-ona, y métodos de uso de las mismas
BR112015018939A2 (pt) formulação, método de preparação de uma formulação, composição, quelante da fórmula (i) e kit
BR112017017643A2 (pt) formulação farmacêutica tópica
EA201892688A1 (ru) Противомикробные композиции для местного применения
EA201490363A1 (ru) Новые составы на основе (триметоксифениламино)пиримидинилов
UY37444A (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y su uso
UY37261A (es) Formulación combinada de tres compuestos antivirales

Legal Events

Date Code Title Description
FB Suspension of granting procedure